1.           Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        North America Immunodiagnostics Market – By Product

1.3.2        North America Immunodiagnostics Market – By Clinical Indication

1.3.3        North America Immunodiagnostics Market – By End User

1.3.4        North America Immunodiagnostics Market– By Country

2.           North America Immunodiagnostics Market – Key Takeaways

3.       Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Immunodiagnostics Market– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.3       Experts Opinion

5.           Immunodiagnostics Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increasing Prevalence of Infectious Diseases

5.1.2        Increasing Use of Point-of-Care Immunodiagnostics

5.2       Market Restraints

5.2.1        Inadequate Reimbursement Scenario

5.3       Market Opportunities

5.3.1        Rising Focus On R&D Investment and Expansion by Key Players

5.4       Future Trends

5.4.1        Technological Advancements in The Field of Immunodiagnostics

5.5       Impact Analysis

6.           Immunodiagnostics Market– North America Analysis

6.1       North America Immunodiagnostics Market Revenue Forecast and Analysis

6.1.1        Company Analysis

6.2       Comparative Company Analysis

6.2.1        Market Share Analysis (2021)

6.2.2        Growth Strategy Analysis

6.2.3        Market Positioning of Key Players in Immunodiagnostics Market

6.2.3.1      Abbott

6.2.3.2      F. Hoffmann-La Roche Ltd

7.           Immunodiagnostics Market Analysis and Forecasts To 2028 – By Product

7.1       Overview

7.2       North America Immunodiagnostics Market, By Product 2021 & 2028 (%)

7.3       Enzyme-Linked Immunosorbent Assays (ELISA)

7.3.1        Overview

7.3.2        Enzyme-Linked Immunosorbent Assays (ELISA) Market Revenue and Forecast to 2028 (US$ Million)

7.4       Chemiluminescence Immunoassays (CLIA)

7.4.1        Overview

7.4.2        Chemiluminescence Immunoassays (CLIA) Market Revenue and Forecast to 2028 (US$ Million)

7.4.3        Vitamin D Assay

7.4.3.1      Overview

7.4.3.2      Vitamin D Assay Market Revenue and Forecast to 2028 (US$ Million)

7.4.4        HIV Detection

7.4.4.1      Overview

7.4.4.2      HIV Detection Market Revenue and Forecast to 2028 (US$ Million)

7.4.5        HIV Ag/Ab Combo Assay

7.4.5.1      Overview

7.4.5.2      HIV Ag/Ab Combo Assay Market Revenue and Forecast to 2028 (US$ Million)

7.4.6        Others

7.4.6.1      Overview

7.4.6.2      Others Market Revenue and Forecast to 2028 (US$ Million)

7.5       Radioimmunoassays (RIA)

7.5.1        Overview

7.5.2        Radioimmunoassays (RIA) Market Revenue and Forecast to 2028 (US$ Million)

7.6       Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ Million)

8.           Immunodiagnostics Market Analysis and Forecasts To 2028 – By Clinical Indication

8.1       Overview

8.2       North America Immunodiagnostics Market, By Clinical Indication 2021 & 2028 (%)

8.3       Infectious Diseases

8.3.1        Overview

8.3.2        Infectious Diseases Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        COVID-19

8.3.3.1      Overview

8.3.3.2      COVID-19 Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Lyme

8.3.4.1      Overview

8.3.4.2      Lyme Market Revenue and Forecast to 2028 (US$ Million)

8.3.5        Zika

8.3.5.1      Overview

8.3.5.2      Zika Market Revenue and Forecast to 2028 (US$ Million)

8.3.6        Infection Management

8.3.6.1      Overview

8.3.6.2      Infection Management Market Revenue and Forecast to 2028 (US$ Million)

8.3.7        TORCH

8.3.7.1      Overview

8.3.7.2      TORCH Market Revenue and Forecast to 2028 (US$ Million)

8.3.8        Tuberculosis

8.3.8.1      Overview

8.3.8.2      Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)

8.3.9        Treponema

8.3.9.1      Overview

8.3.9.2      Treponema Market Revenue and Forecast to 2028 (US$ Million)

8.3.10     Measles and Mumps

8.3.10.1    Overview

8.3.10.2    Measles and Mumps Market Revenue and Forecast to 2028 (US$ Million)

8.3.11     EBV

8.3.11.1    Overview

8.3.11.2    EBV Market Revenue and Forecast to 2028 (US$ Million)

8.3.12     VZV

8.3.12.1    Overview

8.3.12.2    VZV Market Revenue and Forecast to 2028 (US$ Million)

8.4       Hepatitis+HIV

8.4.1        Overview

8.4.2        Hepatitis+HIV Market Revenue and Forecast to 2028 (US$ Million)

8.5       Gastrointestinal

8.5.1        Overview

8.5.2        Gastrointestinal Market Revenue and Forecast to 2028 (US$ Million)

8.6       Metabolics

8.6.1        Overview

8.6.2        Metabolics Market Revenue and Forecast to 2028 (US$ Million)

8.7       Endocrinology

8.7.1        Overview

8.7.2        Endocrinology Market Revenue and Forecast to 2028 (US$ Million)

8.7.3        Hypertension

8.7.3.1      Overview

8.7.3.2      Hypertension Market Revenue and Forecast to 2028 (US$ Million)

8.7.4        GROWTH

8.7.4.1      Overview

8.7.4.2      GROWTH Market Revenue and Forecast to 2028 (US$ Million)

8.7.5        Diabetes

8.7.5.1      Overview

8.7.5.2      Diabetes Market Revenue and Forecast to 2028 (US$ Million)

8.7.6        Thyroid

8.7.6.1      Overview

8.7.6.2      Thyroid Market Revenue and Forecast to 2028 (US$ Million)

8.7.7        Reproductive Endocrinology

8.7.7.1      Overview

8.7.7.2      Reproductive Endocrinology Market Revenue and Forecast to 2028 (US$ Million)

9.           Immunodiagnostics Market Analysis and Forecasts To 2028 – By End User

9.1       Overview

9.2       North America Immunodiagnostics Market, By End User 2021 & 2028 (%)

9.3       Hospitals

9.3.1        Overview

9.3.2        Hospitals Market Revenue and Forecast to 2028 (US$ Million)

9.4       Clinics

9.4.1        Overview

9.4.2        Clinics Market Revenue and Forecast to 2028 (US$ Million)

9.5       Diagnostics Laboratories

9.5.1        Overview

9.5.2        Diagnostic Laboratories Market Revenue and Forecast to 2028 (US$ Million)

9.6       Academic and Research Institutes

9.6.1        Overview

9.6.2        Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.7       Others

9.7.1        Overview

9.7.2        Others Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Immunodiagnostics Market – Country Analysis

10.1    North America: Immunodiagnostics Market

10.1.1     Overview

10.1.2     North America: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.3     North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.3.1    North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

10.1.4     North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.4.1    North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.4.2    North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.5     North America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6     North America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1    US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1    US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2    US Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2.1        US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

10.1.6.1.3    US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.3.1        US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.3.2        US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.4    US: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6.2    Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1    Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2    Canada Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2.1        Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.3    Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.3.1        Canada Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.3.2        Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.4    Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6.3    Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1    Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2    Mexico Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2.1        Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.3    Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.3.1        Mexico Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.3.2        Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.4    Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        North America: Impact Assessment of COVID-19 Pandemic

12.     Immunodiagnostics Market –Industry Landscape

12.1    Overview

12.2    Growth Strategies in the Immunodiagnostics Market (%)

12.3    Organic Developments

12.3.1     Overview

12.4    Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1    Abbott Laboratories

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    F. Hoffmann-La Roche Ltd

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    DiaSorin S.p.A.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Danaher Corp

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Thermo Fisher Scientific Inc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Siemens Healthineers AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Financial Overview

13.6.4     SWOT Analysis

13.6.5     Key Developments

13.7    PerkinElmer Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    bioMerieux SA

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             Infectious Diseases and Funding

Table 2.             North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

Table 4.             North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 6.             North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 7.             North America Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 8.             US Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 9.             US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

Table 10.          US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 12.          US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 13.          US Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 14.          Canada Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 15.          Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 16.          Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          Canada Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 18.          Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 19.          Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20.          Mexico Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 21.          Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 22.          Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 23.          Mexico Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 24.          Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 25.          Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments in the Immunodiagnostics Market

Table 27.          Inorganic Developments in the Immunodiagnostics Market

Table 28.          Glossary of Terms, Immunodiagnostic Market

LIST OF FIGURES

Figure 1.           Immunodiagnostics Market Segmentation

Figure 2.           Immunodiagnostics Market Segmentation, By Country

Figure 3.           North America Immunodiagnostics Market Overview

Figure 4.           Enzyme-Linked Immunosorbent Assays (ELISA) Held the Largest Share of the Product Segment in Immunodiagnostics Market

Figure 5.           US Held Largest Market Share During Forecast Period

Figure 6.           North America Immunodiagnostics Market– Leading Country Markets (US$ Million)

Figure 7.           North America Immunodiagnostics Market, Industry Landscape

Figure 8.           North America PEST Analysis

Figure 9.           Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 10.        North America Immunodiagnostics Market – Revenue Forecast and Analysis – 2020- 2028

Figure 11.        Market Share Analysis of Key Players in Immunodiagnostics Market

Figure 12.        North America Immunodiagnostics Market – Comparative Company Analysis

Figure 13.        North America Immunodiagnostics Market – Growth Strategy Analysis

Figure 14.        North America Immunodiagnostics Market, by Product 2021 & 2028 (%)

Figure 15.        Enzyme-Linked Immunosorbent Assays (ELISA) Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Chemiluminescence Immunoassays (CLIA) Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Vitamin D Assay Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        HIV Detection Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        HIV Ag/Ab Combo Assay Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Others Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Radioimmunoassays (RIA) Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Others Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        North America Immunodiagnostics Market, by Clinical Indication 2021 & 2028 (%)

Figure 24.        Infectious Diseases Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        COVID-19 Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Lyme Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.        Zika Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.        Infection Management Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.        TORCH Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        2.3.5 Tuberculosis Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        Treponema Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.        Measles and Mumps Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33.        EBV Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.        VZV Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35.        Hepatitis+HIV Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        Gastrointestinal Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Metabolics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Endocrinology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Hypertension Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40.        GROWTH Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41.        Diabetes Market Revenue and Forecasts To 2028 (US$ Million)

Figure 42.        Throid Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43.        Reproductive Endocrinology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 44.        North America Immunodiagnostics Market, by End User 2021 & 2028 (%)

Figure 45.        Hospitals Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        Clinics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47.        Diagnostics Laboratories Market Revenue and Forecasts to 2028 (US$ Million)

Figure 48.        Research & Academic Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 50.        North America: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 51.        North America Immunodiagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 52.        North America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

Figure 53.        US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 54.        Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 55.        Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 56.        Impact of COVID-19 Pandemic on North American Countries Markets

Figure 57.        Growth Strategies in the Immunodiagnostics Market (%)